The program caters for the breadth of membership from both organizations. After a number of years absence, the highly popular and entertaining debate returns this year. Steve Hood will be presiding as 'ringmaster' as Kevin Brady (UCB) and Ben Krippendorf (Roche) go head-to-head with Dennis Smith (DMDG Fellow) and Barry Jones (AstraZeneca) to debate whether "Lipinski Rules are no longer relevant – Future drugs will need to be >5 kDa if they are to become 'profitable' medicines."
Another highlight of the meeting will be a 'Candlelight Lecture' to be given by Magnus Ingelman-Sundberg. For more information about the event click here.